dianas 10(1) > Barrios-Gumiel etal
dianas | Vol 10 Num 1 | marzo 2021 | e202103fa
Theoretical development for the discovery of a drug as a treatment of primary dysmenorrhea.
Universidad de Alcalá.
a. oscar.barrios@edu.uah.es b. mcuesta.1@alumni.unav.es; maria.cuesta@edu.uah.es c. mariadm.2898@gmail.com d. gonzaalezmary@gmail.com
VI Congreso de Señalización Celular, SECUAH 2021.
29 de marzo a 30 de abril, 2021. Universidad de Alcalá. Alcalá de Henares, Madrid. España.
primary dysmenorrhea; drug discovery
Primary dysmenorrhea is a gynaecological disease that causes pain at the beginning of menstruation without any identifiable factor that causes it. It is a very prevalent disease among the female population. However, it has not received the necessary attention to be able to alleviate it. Therefore, we propose a theoretical development whose main objective is to find a drug that specifically mitigates it. In this way, we propose both high-throughput screening and pre-clinical studies in vitro and in vivo. All these applying techniques established and recognized by the scientific community. By this way, we want to encourage the investigation of primary dysmenorrhea, a disease that is as underlying as it is neglected.
Citation: Barrios Gumiel, Óscar; Cuesta Corral, María; Delgado Marín, María; González Morán, María (2021) Theoretical development for the discovery of a drug as a treatment of primary dysmenorrhea. Proceedings of the VI Congreso de Señalización Celular, SECUAH 2021. 29 de marzo a 30 de abril, 2021. Universidad de Alcalá. Alcalá de Henares, Madrid. España. dianas 10 (1): e202103fa. ISSN 1886-8746 (electronic) journal.dianas.e202103fa https://dianas.web.uah.es/journal/e202103fa. URI http://hdl.handle.net/10017/15181
Copyright: © Barrios-Gumiel, Cuesta-Corral M, Delgado-Marín M, González-Morán M. Some rights reserved. This is an open-access work licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. http://creativecommons.org/licenses/by-nc-nd/4.0/